The Translational Genomics Research Institute
PLEASE
The Translational Genomics Research Institute at a glance
- Total assets
- $136,062,120
- -8.4% vs 2024
- Revenue (2025)
- $75,913,310
- -11.6% vs 2024
- Net investment income (2025)
- $2,721,272
- -79.2% vs 2024
- Expenses (2025)
- $86,279,860
- +2.2% vs 2024
- Latest 990 filing
- Form 990, 2025 View filing
Data from IRS Form 990, 2025; updated September 2026.
Who The Translational Genomics Research Institute funds
How this funder distributes its grants
Grant Size Distribution
2 grants across all recorded years
The most common grant size was in the $250–500K range: 1 grant of 2 (50%).
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2022 to 2023, annual grant giving ranged from $328K (2022) to $1.8M (2023). In 2023 it made 1 grant totaling $1.8M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| City of Hope National Medical Center Duarte, CA | Project Support | $1,802,912 |
Ready to take the next step with The Translational Genomics Research Institute?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2025 | $136,062,120 | $75,913,310 | $86,279,860 | — | — | $2,721,272 |
| 2024 | $148,610,558 | $85,916,307 | $84,441,597 | — | — | $13,098,742 |
| 2023 | $145,155,331 | $49,618,841 | $81,144,473 | $1,802,912 | 1 | $2,399,109 |
| 2022 | $174,203,210 | $47,789,496 | $74,504,945 | $328,217 | 1 | $3,778,567 |
| 2021 | $224,233,974 | $175,687,790 | $99,192,595 | — | — | $68,189,525 |
| 2020 | $140,363,431 | $74,149,393 | $78,803,060 | — | — | $406,035 |
| 2019 | $140,891,715 | $77,428,548 | $64,872,822 | — | — | $479,922 |
About The Translational Genomics Research Institute
Based on IRS filings
The Translational Genomics Research Institute is a public charity focused on Medical Research, based in Phoenix, AZ. IRS filing data is available from 2019 through 2025. As of 2025, the organization holds $136.1M in total assets. Net investment income was $2.7M.
Focus Areas
Leadership & Key People
Officers and directors from IRS filings
The Translational Genomics Research Institute is led by Robert W. Stone, Board, Vice Chrm, Coh CEO & President on every filing since 2019; 14 of 29 officers listed in 2025 are compensated.
Officers on the 2025 filing
Robert W. Stone
Board, Vice Chrm, Coh CEO & President
On filings since 2019
1 hr/week
No compensation reported
Jeffrey M. Trent PhD
Board Member, President & Science Director
On filings since 2019
39 hrs/week
No compensation reported
William J. Post
Board Member & Chairman
On filings since 2019
1 hr/week
No compensation reported
Matt Huentelman
Division Director & Neurogenetics
Professor → Division Director & Neurogenetics, 2025
On filings since 2024
40 hrs/week
$438K (2024) → $416K (2025)
Daniel Von Hoff
Tgen Distinguished Professor, Executive Vice President & Molecular Medicine Division
Physician in Chief → Tgen Distinguished Professor, Executive Vice President & Molecular Medicine Division, 2025
On filings since 2019
40 hrs/week
$740K (2019) → $1M (2025)
Manuel Estrada
CFO & Assistant Treasurer
On filings since 2019
39 hrs/week
$311K (2019) → $519K (2025)
Michael Berens
Deputy Director & Strategic Initiatives
Deputy Director of Research → Deputy Director & Strategic Initiatives, 2025
On filings since 2019
40 hrs/week
$397K (2019) → $503K (2025)
Stephanie McRae
General Counsel & Assistant Secretary
On filings since 2019
40 hrs/week
$215K (2019) → $461K (2025)
Sunil Sharma
Physician in Chief
Deputy Director of Clinic. Sciences → Physician in Chief, 2025
On filings since 2019
40 hrs/week
$529K (2019) → $613K (2025)
Teresa Burleson
Chief Operating Officer
On filings since 2019
39 hrs/week
$567K (2019) → $874K (2025)
Nicholas Schork
Deputy Director & Quantitative Sciences
Professor → Deputy Director & Quantitative Sciences, 2025
On filings since 2020
40 hrs/week
$384K (2020) → $493K (2025)
Galen Perry
Senior Vice President of Mktg & Communications
On filings since 2021
40 hrs/week
$264K (2021) → $358K (2025)
Kevin Campbell
Chief Information Officer
On filings since 2023
40 hrs/week
$272K (2023) → $311K (2025)
Cristian Tomasetti
Professor
On filings since 2024
40 hrs/week
$633K (2024) → $471K (2025)
Aleksandar Sekulic
Professor
New on the 2025 filing
1 hr/week
$552K (2025)
Robert Kennedy
Vice President & Finance
New on the 2025 filing
40 hrs/week
$354K (2025)
Stephanie Pond
Vice President & Emerging Opportunities
New on the 2025 filing
40 hrs/week
$464K (2025)
Anthony Scott
Board Member
On filings since 2019
1 hr/week
No compensation reported
Bennett Dorrance
Board Member
On filings since 2019
1 hr/week
No compensation reported
David J. Gullen MD
Board Member
On filings since 2019
1 hr/week
No compensation reported
Jennifer A. Parkhurst
Treasurer & Coh CFO
On filings since 2019
No compensation reported
Marilyn Quayle
Board Member
On filings since 2019
1 hr/week
No compensation reported
Pamela Kehaly
Board Member
On filings since 2019
1 hr/week
No compensation reported
Richard Silverman
Board Member
On filings since 2019
1 hr/week
No compensation reported
Sharon Harper
Board Member
On filings since 2019
1 hr/week
No compensation reported
Terry Peets
Board Member
On filings since 2019
1 hr/week
No compensation reported
Cristin O'Callahan
Secretary & Coh General Counsel
On filings since 2022
1 hr/week
No compensation reported
Karen Quintos
Board Member
On filings since 2022
1 hr/week
No compensation reported
Yvette Tremonti
Coh Chief Financial Officer & Treasurer
New on the 2025 filing
1 hr/week
No compensation reported
Former officers (19)
- Former: Kendall Jensen (2019–2024) — Deputy Director of Research Res.
- Former: Cheryl Babo (2022–2024) — General Counsel & Associate
- Former: Gregory D. Schetina (2019–2023) — Former Officer
- Former: James Lowey (2019–2023) — Chief Information Officer
- Former: Timothy McDaniel (2019–2023) — Senior Vice President of Emerg Opp
- Former: Ahuva Odenheimer (2023) — Bioinformatician
- Former: Bradon McDonald (2023) — Computational Scientist II
- Former: Maria Perdigones (2023) — Staff Scientist
- Former: Tania Contente-Cuomo (2023) — Program Manager - Blood Liquid Biopsy
- Former: Cornelis Van den Berg (2019–2022) — Former Officer
- Former: David Haworth (2022) — President & Vidium
- Former: Edward Shaffer (2022) — Vice President, Technology Strategy & Innovation
- Former: Cindy Parseghian (2019–2021) — Board Member
- Former: Janine LoBello (2019–2021) — Ashion Clinical Lab Director
- Former: Thomas Royce (2019–2021) — Executive Director of Emerg Opp
- Former: Julia Bridge (2020–2021) — Professor
- Former: Johanna Distefano (2019–2020) — Professor
- Former: Robert Bulla (2019–2020) — Board Member
- Former: David Duggan (2019) — Associate Professor
Data from IRS Form 990 filings, 2019–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $1.0M, to Daniel Von Hoff (Tgen Distinguished Professor and Executive Vice President, Molecular Medicine Division). 14 officers or directors reported compensation on that filing.
Frequently asked questions about The Translational Genomics Research Institute
How large is The Translational Genomics Research Institute?
The Translational Genomics Research Institute reported $136.1M in total assets on its 2025 IRS Form 990. Its revenue that year was $75.9M.
What is The Translational Genomics Research Institute?
The Translational Genomics Research Institute is a public charity focused on Medical Research, based in Phoenix, AZ. It holds $136.1M in total assets as of 2025.
Where does The Translational Genomics Research Institute operate?
The Translational Genomics Research Institute has awarded grants in California.
What is The Translational Genomics Research Institute's EIN?
The Translational Genomics Research Institute's EIN (Employer Identification Number) is 75-3065445. IRS Form 990 filing data is available on this page for 2019–2025.
Data last updated September 2026. Sourced from IRS Form 990 filings.
Data update history
(5)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2022 (received by the IRS August 14, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS August 13, 2024)
- Added Form 990 for fiscal year 2019 (received by the IRS August 17, 2020)
- Added Form 990 for fiscal year 2025 (received by the IRS August 13, 2026)
- IRS filings on file for fiscal years 2020–2024
Explore Open Grants
Browse active grant opportunities in The Translational Genomics Research Institute's focus areas in our free grants database
Similar Funders
Funders with grantees in common, and similar funders in Arizona
Ima Foundation
Wichita, KS
Assets
$11.4M
Grants
602
Total Given
$831K
Frances and Jack Levy Foundation
Palm Beach, FL
The Frances and Jack Levy Foundation’s 2025 grants supported arts, higher education, Jewish organizations, and social services, with most funding going to organizations in New York and Florida. Grants ranged from $100 to $102,571, with a median of $2,000. It funds only preselected charitable organizations and does not accept unsolicited requests.
Assets
$1.4M
Grants
24
Total Given
$390K
Fred Hutchinson Cancer Center
Seatle, WA
Fred Hutchinson Cancer Center funds cancer and infectious disease research, along with Washington community-led projects in cancer prevention, screening, education, and care access. Research grants vary widely (the 2025 median was about $118,000); its community awards were up to $15,000, and Tribal Community Grants up to $50,000 plus indirect costs. Community programs are focused on Washington State; whether unsolicited requests are accepted is not stated.
Assets
$3.6B
Grants
139
Total Given
$88.2M
Seattle Children's Hospital
Seattle, WA
Seattle Children’s funds pediatric medical research, education, healthcare access, mental health and children’s health initiatives; its external Crossett Fund supports projects benefiting children and youth in Southeast Alaska. Its 2025 grants ranged from $5,326 to $15.3 million, with a median of $57,582, while Crossett awards are capped at $10,000. The Crossett Fund accepts applications year-round; other unsolicited requests are not described.
Assets
$6.0B
Grants
181
Total Given
$56.3M
Alliance NCTN Foundation
Chicago, IL
The foundation funds institutional support for clinical and translational cancer research, including cancer prevention, control, and treatment, through hospitals, universities, and research organizations. Its 2024 grants ranged from $5,150 to $1,765,276, with a median of $17,768, and were concentrated in Minnesota, with additional funding across several U.S. states. The profile does not state whether it accepts unsolicited requests.
Assets
$4.5M
Grants
70
Total Given
$3.6M
The Chicago Community Trust
Chicago, IL
The Chicago Community Trust funds eligible nonprofits working to narrow the wealth gap and meet urgent needs, with priorities including economic mobility, education, jobs, homeownership, and community development in metropolitan Chicago and Cook County. Its 2025 grants had a median of $26,500, though amounts varied widely; the profile does not state whether it accepts unsolicited requests.
Assets
$7.1B
Grants
4,316
Total Given
$1.2B
More similar funders
More Funders in Arizona
The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open
Figures come from The Translational Genomics Research Institute's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
The Translational Genomics Research Institute down — hundreds of funders to go?